Dislipidemias e antipsicóticos atípicos Dyslipidemias and atypical antipsychotics

by Edilberto Amorim de Cerqueira Filho, Fernanda de Sena Arandas, Irismar Reis de Oliveira, Eduardo Pondé de Sena
Published 2006-01-01

Sex differences in side effects of second-generation antipsychotics

by Paterakis Perikles, Sardis Andreas, Leotsakou Christina
Published 2008-04-01

Atypical antipsychotics as add-on treatment in late-life depression

by Cakir S, Senkal Z
Published 2016-09-01

Alstonine as an Antipsychotic: Effects on Brain Amines and Metabolic Changes

by Viviane M. Linck, Ana P. Herrmann, Ângelo L. Piato, Bernardo C. Detanico, Micheli Figueiró, Jorge Flório, Maurice M. Iwu, Christopher O. Okunji, Mirna B. Leal, Elaine Elisabetsky
Published 2011-01-01

Measurement of treatment adherence with antipsychotic agents in patients with schizophrenia

by Xinhua S Ren, Lawrence Herz, Shirley Qian, et al
Published 2009-09-01

Are depot as effective as oral antipsychotics on first-episode psychosis?

by Cristián Orus, David Aceituno
Published 2016-06-01

Intrinsic and Antipsychotic Drug-Induced Metabolic Dysfunction in Schizophrenia

by Zachary Freyberg, Zachary Freyberg, Despoina Aslanoglou, Ripal Shah, Jacob S. Ballon
Published 2017-07-01

The Use of Long-Acting Injectable Antipsychotic Therapy for Schizophrenia

by Jason Jiang, Jeff Bakal, Pierre Chue, Mark Snaterse, Liana Urichuk, Serdar Dursun, Christopher McCabe, Finlay McAlister, Deborah James, Lawrence Richer
Published 2018-09-01

Antipsychotics and Sexual Dysfunction: Sexual Dysfunction - Part III

by Anil Kumar Mysore Nagaraj, Nagesh Brahmavar Pai, Satheesh Rao
Published 2009-11-01

A systematic review of atypical antipsychotic drugs in schizophrenia

by A-.M. Bagnall, L. Jones, L. Ginnelly, R. Lewis, J. Glanville, S. Gilbody, L. Davies, D. Torgerson, J. Kleijnen
Published 2003-01-01

Patient perspectives on antipsychotic treatments and their association with clinical outcomes

by Hong Liu-Seifert, Olawale O Osuntokun, Jenna L Godfrey, et al
Published 2010-09-01

Effects of atypical antipsychotics on neurocognition in euthymic bipolar patients

by Vieta Eduard, Tabarés-Seisdedos Rafael, del Mar Bonnin Caterina, Balanzá-Martinez Vicent, Daban Claire, Amann Benedikt, Martinez-Arán Anabel, Torrent Carla
Published 2010-04-01

Antipsychotics, Metabolic Adverse Effects, and Cognitive Function in Schizophrenia

by Nicole E. MacKenzie, Chantel Kowalchuk, Chantel Kowalchuk, Sri Mahavir Agarwal, Sri Mahavir Agarwal, Kenya A. Costa-Dookhan, Kenya A. Costa-Dookhan, Fernando Caravaggio, Fernando Caravaggio, Philip Gerretsen, Philip Gerretsen, Philip Gerretsen, Araba Chintoh, Araba Chintoh, Gary J. Remington, Gary J. Remington, Gary J. Remington, Valerie H. Taylor, Valerie H. Taylor, Daniel J. Müeller, Daniel J. Müeller, Daniel J. Müeller, Ariel Graff-Guerrero, Ariel Graff-Guerrero, Ariel Graff-Guerrero, Margaret K. Hahn, Margaret K. Hahn, Margaret K. Hahn
Published 2018-12-01

Effect of Atypical Antipsychotics on Fetal Growth: Is the Placenta Involved?

by Sandeep Raha, Valerie H. Taylor, Alison C. Holloway
Published 2012-01-01

Second-generation antipsychotic and diabetes mellitus in children and adolescents

by Carlo Ripoli, Anna Paola Pinna, Faustina Podda, Roberta Zanni, Maria Giada Tronci, Anna Maria Nurchi
Published 2017-12-01

Mechanisms and therapeutic significance of autophagy modulation by antipsychotic drugs

by Ljubica Vucicevic, Maja Misirkic-Marjanovic, Ljubica Harhaji-Trajkovic, Nadja Maric, Vladimir Trajkovic
Published 2018-10-01

Metabolic monitoring of psychiatric patients on second-generation antipsychotics

by Bobotas Konstantinos, Tsiftsoglou Keranio, Georgiadou Olga, Markopoulou Maria
Published 2008-04-01

Comparison of second generation antipsychotics: are there any differences in efficacy?

by Papageorgiou George
Published 2006-02-01

Antipsychotic-associated psoriatic rash – a case report

by Camelia-Eugenia Bujor, Torkel Vang, Jimmi Nielsen, Ole Schjerning
Published 2017-07-01